Literature DB >> 19086353

Mumbai stroke registry (2005-2006)--surveillance using WHO steps stroke instrument--challenges and opportunities.

P M Dalal1, Madhumita Bhattacharjee, Jaee Vairale, Priya Bhat.   

Abstract

BACKGROUND: India will face enormous socioeconomic burden because life expectancy is increasing placing larger numbers of older people at risk of stroke and other chronic diseases. In order to plan prevention strategies, reliable information on stroke epidemiology is required. For uniform data collection (population based), WHO recommends use of STEPS Stroke instrument. STUDY: A well-defined community (H-ward) with verifiable census data, and representative of population structure of Mumbai (Bombay), was selected. The manual on WHO STEPwise approach to stroke surveillance (STEPS; http://www.who.int/chp/steps/Manual.pdf) was the operational protocol.
RESULTS: During the two year study period (Jan 2005 to Dec 2006), 521 new stroke (CVD) cases (males--275 and females--246) were identified; of which 456 (238 males and 218 females) had "first ever stroke"(FES) indicating an annual incidence of 145 per 100,000 persons (CI 95%: 120-170); age adjusted Segi rate: 152/100,000/year (CI 95% 132-172). Two thirds of the FES cases were admitted to health care facilities (Step I: "in-hospital" cases), the remaining 150 (32.8%) either died outside of hospital or were treated at home or nursing homes (Step II: Fatal events in community and Step III: Non-fatal events in community). CVD Diagnosis was supported by CT (Computed Tomography) in 407 (89%) of 456 FES cases: 366 (80.2%) had Ischaemic CVD, 81 (17.7%) had hemorrhagic CVD and 9 (1%) were of unspecified category. The mean age was 66 yrs SD +/- 13.60 and women were older compared with men (mean age 68.9 yrs SD +/- 13.12 versus 63.4 yrs SD +/- 13.53). Hypertension (BP more than 140/90 mm Hg) alone or in various combinations was present in 378 ( 82.8%) cases. Case fatality at 28 days after the FES stroke was 29.8%. Of 320 surviving patients 38.5% had moderate to severe disability.
CONCLUSIONS: WHO STEPs stroke surveillance Instrument is simple to use and, practical for community surveys. The data are useful for planning stroke prevention campaigns on public awareness and education with regard to diet, exercise, blood pressure control and early symptoms of minor strokes.

Entities:  

Mesh:

Year:  2008        PMID: 19086353

Source DB:  PubMed          Journal:  J Assoc Physicians India        ISSN: 0004-5772


  7 in total

1.  Minimising disability in stroke survivors.

Authors:  P M Dalal; M Bhattacharjee
Journal:  Ann Indian Acad Neurol       Date:  2009-01       Impact factor: 1.383

Review 2.  A comprehensive review of prehospital and in-hospital delay times in acute stroke care.

Authors:  K R Evenson; R E Foraker; D L Morris; W D Rosamond
Journal:  Int J Stroke       Date:  2009-06       Impact factor: 5.266

Review 3.  Stroke in South Asian countries.

Authors:  Mohammad Wasay; Ismail A Khatri; Subhash Kaul
Journal:  Nat Rev Neurol       Date:  2014-02-11       Impact factor: 42.937

Review 4.  Emergency care surveillance and emergency care registries in low-income and middle-income countries: conceptual challenges and future directions for research.

Authors:  Hani Mowafi; Christine Ngaruiya; Gerard O'Reilly; Olive Kobusingye; Vikas Kapil; Andres Rubiano; Marcus Ong; Juan Carlos Puyana; Akm Fazlur Rahman; Rashid Jooma; Blythe Beecroft; Junaid Razzak
Journal:  BMJ Glob Health       Date:  2019-07-29

5.  Risk factors and 30-day case fatality of first-ever stroke in Basrah, Iraq.

Authors:  Jasim N Al-Asadi; Husam A Habib
Journal:  Niger Med J       Date:  2014-05

6.  TIME OF PRESENTATION OF STROKE PATIENTS FOR CT IMAGING IN A NIGERIAN TERTIARY HOSPITAL.

Authors:  G I Ogbole; M O Owolabi; O Ogun; O A Ogunseyinde; A Ogunniyi
Journal:  Ann Ib Postgrad Med       Date:  2015-06

7.  QTc Interval Prolongation and Hemorrhagic Stroke: Any Difference Between Acute Spontaneous Intracerebral Hemorrhage and Acute Non-traumatic Subarachnoid Hemorrhage?

Authors:  Osama Shukir Muhammed Amin; Sarwer Jamal Al-Bajalan; Alaa Mubarak
Journal:  Med Arch       Date:  2017-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.